Oncologist’s Representations of Anticancer Treatments for Patients With Advanced‐Stage Cancer: New Perspectives From the COVID‐19 Crisis
European Journal of Cancer Care · 2026-01 · 2026 (1)
DOI: 10.1155/ecc/7478375 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer Care, online erschienen am 06.04.2026. Verfasst von Chloé Calvez und 7 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut National Du Cancer.
Abstract (Originalsprache)
Introduction
In the context of the COVID‐19 pandemic, scientific societies of oncology issued guidelines to limit the spread of the virus, in particular by limiting the prescription of cancer treatments with palliative intent. This qualitative study adopts a psychosocial perspective to explore how oncologists experienced these guidelines, and what this reveals about their representations and practices concerning end‐of‐life treatments.
Methods
Conducted in a comprehensive cancer center, the study is based on a mixed‐method strategy involving 10 semistructured interviews with oncologists and observation of 13 consultations.
Results
The oncologists stated that they were complying with the guidelines, which was perceived as an external argument of authority that made it easier to announce the cessation of treatment. The analysis highlights the sacralization of chemotherapy, a shared feeling of guilt at the idea of stopping cancer treatments, and a representation of palliative care as the moment when there is “nothing more to be done.” Discussion The fact that the oncologists reported that previous practices had been reinstated once the health crisis had passed reveals the psychosocial logics at work in their decision‐making and communication practices. This study recommends the creation of workshops to raise awareness of the psychosocial factors that influence chemotherapy prescriptions in the advanced stages of the disease.
Förderung
- Institut National Du Cancer
Zitieren
APA
Calvez, C., Mininel, F., Montgolfier, S. D., Gonçalves, A., Leleu, U., Rochigneux, P., Proux, A., & Restivo, L. (2026). Oncologist’s Representations of Anticancer Treatments for Patients With Advanced‐Stage Cancer: New Perspectives From the COVID‐19 Crisis. European Journal of Cancer Care, 2026(1). https://doi.org/10.1155/ecc/7478375
Vancouver
Calvez C, Mininel F, Montgolfier SD, Gonçalves A, Leleu U, Rochigneux P, et al. Oncologist’s Representations of Anticancer Treatments for Patients With Advanced‐Stage Cancer: New Perspectives From the COVID‐19 Crisis. European Journal of Cancer Care. 2026;2026(1). doi:10.1155/ecc/7478375
BibTeX
@article{Calvez2026,
author = {Calvez, Chloé and Mininel, Francesca and Montgolfier, Sandrine de and Gonçalves, Anthony and Leleu, Ulrick and Rochigneux, Philippe and Proux, Aurélien and Restivo, Léa},
title = {Oncologist’s Representations of Anticancer Treatments for Patients With Advanced‐Stage Cancer: New Perspectives From the COVID‐19 Crisis},
journal = {European Journal of Cancer Care},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ecc/7478375}
}
EUVIMED